# Prevalence and genetic etiology of poly-cystic ovarian syndrome (PCOS) in Mauritania

**Authors:** Marieme Elwafi, Abdi Ahmed, Omar Akhouayri, Ahmed Zein, Hamma Abdelkader, Roughaya Selman, Ahmed Houmeida

PMC · DOI: 10.3389/frph.2025.1461405 · 2025-06-09

## TL;DR

This study examines the prevalence of PCOS in Mauritania and identifies genetic variants possibly linked to the condition.

## Contribution

The study reports on the prevalence of PCOS in Mauritania and explores specific gene polymorphisms associated with the disorder.

## Key findings

- The prevalence of PCOS was found to be 7.8% in the studied cohort.
- LHCGR rs2293275 and ESR1 rs2234693 polymorphisms were associated with PCOS.
- The rs104893836 polymorphism was not found in any PCOS cases tested.

## Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder characterized by polycystic ovaries, oligoanovulation, hyperandrogenism and infertility. The exact specific causes of this disease have not yet been identified, but there is evidence of significant genetic involvement.

The present study aimed to evaluate the prevalence of PCOS and explore its gene polymorphisms in the Mauritanian population.

Files of 2,100 women patients attending two gynaecologic clinics of Nouakchott were retrospectively analysed to identify PCOS patients based on the 2003 Rotterdam Criterion. A genetic study used Sanger sequencing to search for six known SNPs in LHCGR (rs2293275), FSHR (rs6166), ESR1 (rs2234693), GnRHR (rs104893836), miR-126 (rs4636297), and miR-499 (rs3746444) among 8 familial PCOS cases and 3 sporadic patients. A more extended search was then carried out exclusively for LHCGR rs2293275 on 56 PCOS patients.

The prevalence of PCOS was 7.8% in this cohort. The occurrence of LHCGR rs2293275 (T>C, G; p. Asn 312 Ser) and ESR1 rs2234693 (T>C, G) polymorphisms in the PCOS screened patients suggests a likely association of these variants with the disease. However, rs104893836 polymorphism was not found in any of the tested PCOS cases.

Although yet to be confirmed in larger size cohort, these data could contribute to improving the exploration, referral, and treatment of PCOS in Mauritania.

## Linked entities

- **Genes:** LHCGR (luteinizing hormone/choriogonadotropin receptor) [NCBI Gene 3973], FSHR (follicle stimulating hormone receptor) [NCBI Gene 2492], ESR1 (estrogen receptor 1) [NCBI Gene 2099], GNRHR (gonadotropin releasing hormone receptor) [NCBI Gene 2798], MIR126 (microRNA 126) [NCBI Gene 406913], MIR499A (microRNA 499a) [NCBI Gene 574501]
- **Diseases:** Polycystic ovary syndrome (MONDO:0008487), PCOS (MONDO:0008487)

## Full-text entities

- **Genes:** LHCGR (luteinizing hormone/choriogonadotropin receptor) [NCBI Gene 3973] {aka HHG, LCGR, LGR2, LH/CG-R, LH/CGR, LHR}, MIR126 (microRNA 126) [NCBI Gene 406913] {aka MIRN126, miRNA126, mir-126}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, FSHR (follicle stimulating hormone receptor) [NCBI Gene 2492] {aka FSHR1, FSHRO, LGR1, ODG1}, MIR499A (microRNA 499a) [NCBI Gene 574501] {aka MIR499, MIRN499, hsa-mir-499a, mir-499a}, GNRHR (gonadotropin releasing hormone receptor) [NCBI Gene 2798] {aka GNRHR1, GRHR, HH7, LHRHR, LRHR}
- **Diseases:** Polycystic ovary syndrome (MESH:D011085), PCOS (MESH:D010051), hyperandrogenism (MESH:D017588), infertility (MESH:D007246), endocrine and metabolic disorder (MESH:D004700)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs3746444, p. Asn 312 Ser, rs2234693, rs4636297, rs6166, rs104893836

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12183262/full.md

---
Source: https://tomesphere.com/paper/PMC12183262